Isothiazole and isoxazole fused pyrimidones as PDE7 inhibitors: SAR and pharmacokinetic evaluation.
Abhisek Banerjee, Pravin S Yadav, Malini Bajpai, Ramachandra Rao Sangana, Srinivas Gullapalli, Girish S Gudi, Laxmikant A Gharat
Glenmark Pharmaceuticals Limited, Navi Mumbai, Maharashtra 400 709, India.
Bioorganic & medicinal chemistry letters 2012 May 1The synthesis and structure-activity relationship studies of isothiazole and isoxazole fused pyrimidones as PDE7 inhibitors are discussed. The pharmacokinetic profile of 10 and 21 with adequate CNS penetration, required for in vivo Parkinson's disease models, are disclosed. Copyright © 2012 Elsevier Ltd. All rights reserved.
Citation
Abhisek Banerjee, Pravin S Yadav, Malini Bajpai, Ramachandra Rao Sangana, Srinivas Gullapalli, Girish S Gudi, Laxmikant A Gharat. Isothiazole and isoxazole fused pyrimidones as PDE7 inhibitors: SAR and pharmacokinetic evaluation. Bioorganic & medicinal chemistry letters. 2012 May 1;22(9):3223-8
Mesh Tags
Substances
PMID: 22487174
View Full Text
